Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Osteosarcoma.

Trial Profile

Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Osteosarcoma.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Everolimus (Primary)
  • Indications Osteosarcoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Aug 2013 Planned end date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
    • 25 Mar 2013 Planned end date changed from 1 Mar 2018 to 1 Dec 2013 as reported by ClinicalTrials.gov.
    • 24 Jun 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top